Cambridge Nutritional Sciences PLC Warrant Expiry and Block Admission Cancellation (0080T)
November 10 2023 - 2:00AM
UK Regulatory
TIDMCNSL
RNS Number : 0080T
Cambridge Nutritional Sciences PLC
10 November 2023
Cambridge Nutritional Sciences plc
(the 'Company' or 'CNS')
Warrant Expiry
and
Block Admission Cancellation
Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist
medical diagnostics company focused on promoting a personalised and
functional approach to health and nutrition, announces that all
warrants issued alongside its capital raise announced 6 May 2022
have now expired ("Warrants").
Further to the above the Company has made application to AIM to
cancel the Company's Block Admission, which was originally
established to facilitate the issuance of ordinary shares following
receipt of any exercise of the Warrants (the "Cancellation"). The
Cancellation will become effective Monday 13 November, as such no
further interim returns will be published in relation to the
Company's Block Admission. The Balance of ordinary shares under the
Block Admission not issued/allotted at the time of Cancellation is
90,000,000.
Contacts:
Cambridge Nutritional Sciences plc www.cnsplc.com
Jag Grewal, Chief Executive Officer via Walbrook PR
Cavendish Capital Markets Limited Tel: 020 7220 0500
Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or CNS@walbrookpr.com
Paul McManus / Charlotte Edgar Mob: 07980 541 893 / 07884 664 686
Sam Allen Mob: 07502 558 258
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist
medical diagnostics company focused on industry-leading Health and
Nutrition products.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCKZMGMNLGGFZM
(END) Dow Jones Newswires
November 10, 2023 02:00 ET (07:00 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Aug 2023 to Aug 2024